Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | PPID | Q08752 | 2/20 | 0.45 |
| ▸ | PPIB | P23284 | 1/20 | 0.45 |
| ▸ | PPIA | P62937 | 1/20 | 0.45 |
| ▸ | PPIG | Q13427 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL265730 | 0.98 | GAA (0.61) | GAAALDH1A1TSHRMGAMSI | |
| Pyrimidine SCHEMBL10479184 | 0.85 | GAA (0.49) | GAAALDH1A1TSHRHPGDMEN1 | |
| SCHEMBL28757970 | 0.84 | GAA (0.46) | GAAALDH1A1TSHRHPGDMEN1 | |
| SCHEMBL12323562 | 0.83 | GAA (0.63) | GAAALDH1A1TSHRMGAMSI | |
| SCHEMBL5184954 | 0.83 | GAA (0.68) | GAAALDH1A1TSHRMGAMSI | |
| SCHEMBL3584747 | 0.83 | GAA (0.68) | GAAALDH1A1TSHRMGAMSI | |
| Hydrochloric Acid SCHEMBL713839 | 0.82 | GAA (0.44) | GAAALDH1A1TSHRHPGDMEN1 | |
| SCHEMBL23714146 | 0.82 | GAA (0.49) | GAAALDH1A1TSHRMGAMSI | |
| SCHEMBL14890530 | 0.82 | GAA (0.61) | GAAALDH1A1TSHRMGAMSI | |
| SCHEMBL25412979 | 0.81 | HTR2C (0.47) | GAAALDH1A1LMNARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101460198-B | Thermosensitive polyphosphazene-bioactive molecule conjugate, preparation method and application thereof | KOREA INST SCI & TECH | 2013-08-07 | — | — | CN | claimed |
| CN-101460198-A | Thermosensitive polyphosphazene-bioactive molecule conjugate, preparation method and application thereof | KOREA INST SCI & TECH (KR) | 2009-06-17 | — | — | CN | claimed |
| US-20060040871-A1 | Bacterial transforming agent | PHARMACEUTICA LIMITED (GB) | 2006-02-23 | — | — | US | claimed |
| EP-1553981-A1 | BACTERIAL TRANSFORMING AGENT | Pharmaceutica Limited (GB) | 2005-07-20 | — | — | EP | claimed |
| WO-2003101488-A1 | BACTERIAL TRANSFORMING AGENT | PHARMACEUTICA LIMITED (GB) | 2003-12-11 | — | — | WO | claimed |
| EP-0644887-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID. | SMITHKLINE BEECHAM PLC (GB) | 1995-03-29 | — | — | EP | claimed |
| CN-1095069-A | Novel process for the preparation and/or purification of clavulanic acid or pharmaceutically acceptable salts or esters thereof | SMITHKLINE BEECHAM PLC (GB) | 1994-11-16 | — | — | CN | claimed |
| WO-1993025557-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1993-12-23 | — | — | WO | claimed |
| US-20230348476-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | 3 2 PHARMA LLC (US) | 2023-11-02 | — | — | US | disclosed |
| EP-3468563-B1 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | UNIV OREGON STATE (US) | 2023-09-13 | — | — | EP | disclosed |
| US-11655253-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | 3+2 PHARMA, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| EP-3998060-A1 | HAIR COSMETIC | Kao Corporation (JP) | 2022-05-18 | — | — | EP | disclosed |
| US-11234916-B2 | Hair cosmetic | KAO CORPORATION (JP) | 2022-02-01 | — | — | US | disclosed |
| US-20210069081-A1 | HAIR COSMETIC | KAO CORPORATION (JP) | 2021-03-11 | — | — | US | disclosed |
| CN-1095069-A | Novel process for the preparation and/or purification of clavulanic acid or pharmaceutically acceptable salts or esters thereof | SMITHKLINE BEECHAM PLC (GB) | 1994-11-16 | — | — | CN | disclosed |
| WO-1993025557-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1993-12-23 | — | — | WO | disclosed |
| US-4873228-A | 2-oxo-4-carboxy-pyrimidines and their use as anti-malaria and anti-cancer agents | THE UNIVERSITY OF MELBOURNE (AU) | 1989-10-10 | — | — | US | disclosed |
| EP-0260057-A2 | 2-Oxo-4-carboxy-pyrimidines | THE UNIVERSITY OF MELBOURNE (AU) | 1988-03-16 | — | — | EP | disclosed |
| US-4033974-A | Pyridylmethyl esters of N-(phenoxyalkanoyl)peptide derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
| US-3956484-A | Pyridylmethyl esters of N-(phenoxyalkanoyl)peptide derivatives for therepeutic use | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348476-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | CREBBP, CREB1, EP300 | GAA 1312/4885ALDH1A1 2132/4885TSHR 4563/4885 |
| US-20060040871-A1 | Bacterial transforming agent | BCAT1, BCAT2, SLC11A2 | GAA 1773/4885ALDH1A1 2005/4885TSHR 2413/4885 |
| US-20210069081-A1 | HAIR COSMETIC | TYR, CUTA, H1-0 | GAA 1978/4885ALDH1A1 494/4885TSHR 2456/4885 |
| US-11655253-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | CREBBP, CREB1, EP300 | GAA 1312/4885ALDH1A1 2132/4885TSHR 4563/4885 |
| US-11234916-B2 | Hair cosmetic | TYR, CUTA, H1-0 | GAA 1978/4885ALDH1A1 494/4885TSHR 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.